[医药制造业] [2025-03-03]
TEMPUS AI 是一家立足于 AI 技术的医疗科技公司。公司为医疗保健提供者、制药公司等提供新一代测序诊断、分子分型及病理检测服务,以及去标识化的临床、分子和影像数据许可库、分析和云计算工具、临床试验匹配服务等服务。人工智能平台与美国 2000 多家医院相连,可提供 2000 多种应用程序。提供功能包括:为医疗服务提供者寻找合适的临床试验;识别需要紧急护理的患者以确保获得最佳治疗;提供分子影像、病理学切片、放射扫描等多模态临床数据的光学空间基因组学功能。公司专注于精准医疗领域,其主要诊断产品在多个疾病诊断方面发挥关键作用,涵盖肿瘤学、遗传学等多个领域。
[租赁和商务服务业,医药制造业] [2025-03-03]
Clinical trials outsourcing involves partnering with a contract research organization (CRO) to manage specific functions or entire clinical trial activities, rather than maintaining them inhouse. This strategic approach enables trial sponsors to reduce costs, accelerate timelines, focus on core competencies, and streamline workflows. Sponsors aim to enhance research efficiency, optimize associated activities, and ultimately increase the success rate of trial outcomes by outsourcing clinical trials.
[医药制造业,信息传输、软件和信息技术服务业] [2025-03-03]
Clinical trial software, also known as clinical trial management systems (CTMS), are digital platform used to manage clinical trials activities with more efficiency. This software system responsible for managing overall operational aspects of clinical studies from study startup to closeout with the incorporation of digital tools and technologies that reduce human interference and errors in complex trials operations. Clinical research sites used clinical trial software to centralize data related to procedures, subjects, workforce, billing, financials, and much more.
[医药制造业] [2025-03-03]
Contact lens solutions are essential for cleaning, disinfecting, and storing contact lenses. They ensure the durability of the lens and comfort to the wearer by keeping the eyes moistened.
[医药制造业,信息传输、软件和信息技术服务业] [2025-03-01]
生物医药行业:AI制药蓝海,人工智能助力新药开发全流程-“AI+医药健康_系列报告(三)-招商证券
[医药制造业] [2025-03-01]
事件:1月22日,强生公布2024业绩,2024年实现营收888亿美元(+4.3% ),主要来自两大核心业务板块贡献——创新制药和医疗科技, 分别实现了569.64亿美元(+4.0%)以及318.57亿美元(+4.8%)的收入。展望2025年,强生预计2025年的运营销售增长率在2.5%到3.5%之 间,总收入有望达到910亿-919亿美元。
[医药制造业] [2025-03-01]
麻醉药行业深度报告:回答三大关键问 题,看好高壁垒、政策保护的精麻行业 稳健发展
[医药制造业] [2025-03-01]
AI+医疗”解决方案全球市场有望突破千亿美元,有望进入到商业化加速阶段。“AI+医疗”行业人工智能解决方案的全球市场规模预计将由 2022 年的 137 亿美元增至 2030 年的 1,553 亿美元,CAGR 为 35.5%,行业存在爆发式增长机会。政策面上,国内宏观政策利好AI制药,医疗AI三类证审批加速。“AI+ 医疗”相对传统医药研发优势显著,在算法+数据+临床场景闭环构建护城河,“AI+医疗”细分板块享受估值溢价。我们认为“AI+医疗”有望应用于药物研发、 癌症诊断、医学影像、手术机器人等领域,行业或迎来巨变。
[医药制造业] [2025-03-01]
[医药制造业] [2025-02-28]
When a medical emergency arises, an air ambulance is a specially equipped helicopter or aircraft that is used to carry sick or injured patients over distances or terrain that would be too difficult for a traditional ground ambulance to travel.